Localized delivery of mechano-growth factor E-domain peptide via polymeric microstructures improves cardiac function following myocardial infarction
There are scenarios where GLOW is not appropriate, or where it should be delayed until other issues are addressed
Some patients experience rapid weight regain when stopping GLP-1s, which could affect surgical planning if significant weight change occurs
But when chronic stress, poor diet, sleep problems or hormonal shifts disrupt that balance, its as if the thermostat gets jammed on the wrong setting
Reduced Hunger: This medication can help decrease those frequent urges to snack or indulge in large portions
This work was supported by the National Institutes of Health under award numbers 2R01HL115189, P30DK04056, UE5DK137285, and U24 DK132733, and by the National Clinician Scholars Program at the Duke Clinical and Translational Science Institute